CIK 0001563880 · Non-accelerated filer<br>Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450834299
- Phone
- 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | Meeker David P Director | Option exercise · Stock Option (right to buy) | −4,555 | 0 | ||
| 2024-08-19 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise | +16,496 | $1.43 | $24K | 236,811 |
| 2024-08-19 | SCIASCIA THOMAS Chief Scientific Officer | Sale | −16,496 | $2.96 | $49K | 220,315 |
| 2024-08-19 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −16,496 | 0 | ||
| 2024-08-16 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise | +18,660 | $1.43 | $27K | 238,975 |
| 2024-08-16 | SCIASCIA THOMAS Chief Scientific Officer | Sale | −18,660 | $2.76 | $51K | 220,315 |
| 2024-08-16 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −18,660 | 16,496 | ||
| 2024-08-15 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise | +12,745 | $1.43 | $18K | 233,060 |
| 2024-08-15 | SCIASCIA THOMAS Chief Scientific Officer | Sale | −12,745 | $2.79 | $36K | 220,315 |
| 2024-08-15 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −12,745 | 35,156 | ||
| 2024-08-14 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise | +100 | $1.43 | $143 | 220,415 |
| 2024-08-14 | SCIASCIA THOMAS Chief Scientific Officer | Sale | −100 | $2.75 | $275 | 220,315 |
| 2024-08-14 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −100 | 47,901 | ||
| 2024-06-13 | Mathers Edward T Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-13 | VANLENT ANNE Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-13 | Cassella James V Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-13 | Heffernan Michael Thomas Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-13 | Meeker David P Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-13 | Colangelo Dominick Director | Grant or award · Nonstatutory Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-29 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise | +59,354 | $2.19 | $130K | 267,801 |
Page 5 of 9 · 179 trades